Juno Lighting LLC (NASDAQ:JUNO)’s share price shot up 2.1% on Tuesday . The stock traded as high as $30.03 and last traded at $29.79, with a volume of 528,647 shares changing hands. The stock had previously closed at $29.19.

Several research firms have weighed in on JUNO. FBR & Co reaffirmed a “buy” rating on shares of Juno Lighting in a research note on Saturday, July 9th. Leerink Swann reaffirmed a “buy” rating and set a $86.00 target price on shares of Juno Lighting in a research note on Thursday, July 14th. Zacks Investment Research raised Juno Lighting from a “sell” rating to a “hold” rating in a research note on Tuesday, September 6th. Vetr cut Juno Lighting from a “strong-buy” rating to a “buy” rating and set a $38.02 price target for the company. in a research note on Tuesday, August 16th. Finally, Barclays PLC assumed coverage on Juno Lighting in a research note on Wednesday, July 6th. They issued an “equal weight” rating and a $48.00 price target for the company. One investment analyst has rated the stock with a sell rating, four have given a hold rating, ten have given a buy rating and one has assigned a strong buy rating to the company. The company presently has a consensus rating of “Buy” and a consensus price target of $49.00.

The firm’s market capitalization is $3.03 billion. The company has a 50-day moving average price of $31.11 and a 200 day moving average price of $37.04.

This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/09/20/juno-lighting-llc-juno-shares-up-2-1.html

Juno Lighting (NASDAQ:JUNO) last released its quarterly earnings results on Thursday, August 4th. The biopharmaceutical company reported ($0.64) EPS for the quarter, missing the Zacks’ consensus estimate of ($0.41) by $0.23. The firm earned $27.60 million during the quarter, compared to the consensus estimate of $14.26 million. Juno Lighting’s revenue for the quarter was up 121.5% compared to the same quarter last year. During the same quarter in the prior year, the company posted ($0.35) earnings per share. Equities research analysts anticipate that Juno Lighting LLC will post ($2.48) EPS for the current year.

In other news, CEO Hans Edgar Bishop sold 23,042 shares of the firm’s stock in a transaction dated Thursday, September 8th. The stock was sold at an average price of $30.06, for a total transaction of $692,642.52. Following the sale, the chief executive officer now owns 2,541,151 shares of the company’s stock, valued at $76,386,999.06. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, Director Richard Klausner sold 12,000 shares of the firm’s stock in a transaction dated Friday, June 24th. The stock was sold at an average price of $40.71, for a total value of $488,520.00. Following the sale, the director now directly owns 846,799 shares in the company, valued at approximately $34,473,187.29. The disclosure for this sale can be found here.

Several large investors have recently added to or reduced their stakes in the company. Boyer & Corporon Wealth Management LLC raised its stake in Juno Lighting by 0.9% in the second quarter. Boyer & Corporon Wealth Management LLC now owns 12,579 shares of the biopharmaceutical company’s stock worth $484,000 after buying an additional 115 shares in the last quarter. Profund Advisors LLC raised its stake in Juno Lighting by 0.4% in the second quarter. Profund Advisors LLC now owns 39,877 shares of the biopharmaceutical company’s stock worth $1,533,000 after buying an additional 148 shares in the last quarter. Legal & General Group Plc raised its stake in Juno Lighting by 5.9% in the second quarter. Legal & General Group Plc now owns 5,470 shares of the biopharmaceutical company’s stock worth $210,000 after buying an additional 306 shares in the last quarter. First Washington CORP raised its stake in Juno Lighting by 1.3% in the second quarter. First Washington CORP now owns 39,700 shares of the biopharmaceutical company’s stock worth $1,526,000 after buying an additional 500 shares in the last quarter. Finally, BlackRock Group LTD raised its stake in Juno Lighting by 2.3% in the second quarter. BlackRock Group LTD now owns 35,436 shares of the biopharmaceutical company’s stock worth $1,363,000 after buying an additional 783 shares in the last quarter.

Juno Lighting Company Profile

5 Day Chart for NASDAQ:JUNO

Receive News & Ratings for Juno Lighting LLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Juno Lighting LLC and related companies with MarketBeat.com's FREE daily email newsletter.